JNJ acquires SWAV for $335/sh cash—a 17% premium to SWAV’s “unaffected” share price on 3/25/24: https://finance.yahoo.com/news/johnson-johnson-acquire-shockwave-medical-103100477.html The nominal deal value is $12.5B (net of SWAV’s cash on hand).